Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2016 Filed May 20, 2016 20:56 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 1,040 | $100.95 | $104,988.00 |
DisclosureSEC source: 0001127602-16-052955 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,345 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 19, 2016 Filed May 20, 2016 20:57 UTC |
DORMAN DAVID WDirector
|
GrantCommon Stock | 2,823 | $100.95 | $284,981.85 |
DisclosureSEC source: 0001127602-16-052956 · form4.xml · nonDerivative · entry 1 DORMAN DAVID W · CIK 0001082870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,292 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 19, 2016 Filed May 20, 2016 20:58 UTC |
Finucane Anne A.Director
|
GrantCommon Stock | 1,040 | $100.95 | $104,988.00 |
DisclosureSEC source: 0001127602-16-052958 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,040 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 19, 2016 Filed May 20, 2016 20:59 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 1,040 | $100.95 | $104,988.00 |
DisclosureSEC source: 0001127602-16-052960 · form4.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,040 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 19, 2016 Filed May 20, 2016 21:01 UTC |
WHITE TONY LDirector
|
GrantCommon Stock | 1,040 | $100.95 | $104,988.00 |
DisclosureSEC source: 0001127602-16-052961 · form4.xml · nonDerivative · entry 1 WHITE TONY L · CIK 0001171315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,452 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| May 16, 2016 Filed Feb 3, 2017 21:14 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
GiftCommon Stock | 1,930 | $104.55 | $201,781.50 |
DisclosureSEC source: 0001127602-17-003879 · form5.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,671.059 Read SEC document |
| May 05, 2016 Filed May 6, 2016 20:26 UTC |
MERLO LARRY JDirector · President and CEO
|
Exercise / conversionStock Option · Derivative | 38,247 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-16-051399 · form4.xml · derivative · entry 7 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,494 Underlying: Common Stock · 38,247 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| May 05, 2016 Filed May 6, 2016 20:26 UTC |
MERLO LARRY JDirector · President and CEO
|
SaleCommon Stock | 38,247 | $105.00 | $4,015,935.00 |
DisclosureSEC source: 0001127602-16-051399 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,133.8769 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| May 05, 2016 Filed May 6, 2016 20:26 UTC |
MERLO LARRY JDirector · President and CEO
|
Exercise / conversionCommon Stock | 38,247 | $36.23 | $1,385,688.81 |
DisclosureSEC source: 0001127602-16-051399 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,380.8769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2016 Filed May 6, 2016 20:28 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
SaleCommon Stock | 7,517 | $105.00 | $789,285.00 |
DisclosureSEC source: 0001127602-16-051401 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,601.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| May 05, 2016 Filed May 6, 2016 20:29 UTC |
GOLD STEPHEN JEVP & CIO
|
Exercise / conversionStock Option · Derivative | 9,798 | $0.00 Strike: $47.29 | $0.00 |
DisclosureSEC source: 0001127602-16-051404 · form4.xml · derivative · entry 6 GOLD STEPHEN J · CIK 0001252005 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,440 Underlying: Common Stock · 9,798 shares Expires 2022-07-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 07/09/2015. Read SEC document |
| May 05, 2016 Filed May 6, 2016 20:29 UTC |
GOLD STEPHEN JEVP & CIO
|
SaleCommon Stock | 9,798 | $105.00 | $1,028,790.00 |
DisclosureSEC source: 0001127602-16-051404 · form4.xml · nonDerivative · entry 2 GOLD STEPHEN J · CIK 0001252005 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,560.3558 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| May 05, 2016 Filed May 6, 2016 20:29 UTC |
GOLD STEPHEN JEVP & CIO
|
Exercise / conversionCommon Stock | 9,798 | $47.29 | $463,347.42 |
DisclosureSEC source: 0001127602-16-051404 · form4.xml · nonDerivative · entry 1 GOLD STEPHEN J · CIK 0001252005 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,358.3558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 02, 2016 Filed Apr 5, 2016 22:57 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 3,192 | $104.82 | $334,585.44 |
DisclosureSEC source: 0001127602-16-048897 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,260.4689 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:34 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantStock Option · Derivative | 286,787 | $104.82 Strike: $104.82 | $30,061,013.34 |
DisclosureSEC source: 0001127602-16-048870 · form4.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,787 Underlying: Common Stock · 286,787 shares Expires 2023-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:34 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantCommon Stock (restricted) | 38,160 | $104.82 | $3,999,931.20 |
DisclosureSEC source: 0001127602-16-048870 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,398 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:34 UTC |
MERLO LARRY JDirector · President and CEO
|
Tax withholdingCommon Stock | 17,583 | $104.82 | $1,843,050.06 |
DisclosureSEC source: 0001127602-16-048870 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,133.8769 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:42 UTC |
Roberts Jonathan CEVP & President, CVS Caremark
|
GrantStock Option · Derivative | 161,318 | $104.82 Strike: $104.82 | $16,909,352.76 |
DisclosureSEC source: 0001127602-16-048878 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,318 Underlying: Common Stock · 161,318 shares Expires 2023-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:42 UTC |
Roberts Jonathan CEVP & President, CVS Caremark
|
GrantCommon Stock (restricted) | 21,465 | $104.82 | $2,249,961.30 |
DisclosureSEC source: 0001127602-16-048878 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,753 F1 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:50 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
GrantStock Option · Derivative | 71,696 | $104.82 Strike: $104.82 | $7,515,174.72 |
DisclosureSEC source: 0001127602-16-048880 · form4.xml · derivative · entry 6 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,696 Underlying: Common Stock · 71,696 shares Expires 2023-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:50 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
GrantCommon Stock (restricted) | 9,540 | $104.82 | $999,982.80 |
DisclosureSEC source: 0001127602-16-048880 · form4.xml · nonDerivative · entry 2 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,556.1706 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:50 UTC |
Foulkes HelenaEVP, President-CVS Pharmacy
|
Tax withholdingCommon Stock | 4,411 | $104.82 | $462,361.02 |
DisclosureSEC source: 0001127602-16-048880 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,899.6389 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:58 UTC |
Denton David MEVP and CFO
|
GrantStock Option · Derivative | 71,696 | $104.82 Strike: $104.82 | $7,515,174.72 |
DisclosureSEC source: 0001127602-16-048882 · form4.xml · derivative · entry 4 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,696 Underlying: Common Stock · 71,696 shares Expires 2023-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:58 UTC |
Denton David MEVP and CFO
|
GrantCommon Stock (restricted) | 9,540 | $104.82 | $999,982.80 |
DisclosureSEC source: 0001127602-16-048882 · form4.xml · nonDerivative · entry 2 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,980 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 21:58 UTC |
Denton David MEVP and CFO
|
Tax withholdingCommon Stock | 12,902 | $104.82 | $1,352,387.64 |
DisclosureSEC source: 0001127602-16-048882 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,266.1391 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:28 UTC |
Moriarty Thomas MEVP & General Counsel
|
GrantStock Option · Derivative | 71,696 | $104.82 Strike: $104.82 | $7,515,174.72 |
DisclosureSEC source: 0001127602-16-048887 · form4.xml · derivative · entry 5 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,696 Underlying: Common Stock · 71,696 shares Expires 2023-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:28 UTC |
Moriarty Thomas MEVP & General Counsel
|
GrantCommon Stock (restricted) | 9,540 | $104.82 | $999,982.80 |
DisclosureSEC source: 0001127602-16-048887 · form4.xml · nonDerivative · entry 2 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,700 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:28 UTC |
Moriarty Thomas MEVP & General Counsel
|
Tax withholdingCommon Stock | 2,972 | $104.82 | $311,525.04 |
DisclosureSEC source: 0001127602-16-048887 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,088.3444 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:32 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
GrantStock Option · Derivative | 53,772 | $104.82 Strike: $104.82 | $5,636,381.04 |
DisclosureSEC source: 0001127602-16-048888 · form4.xml · derivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,772 Underlying: Common Stock · 53,772 shares Expires 2023-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:32 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
GrantCommon Stock (restricted) | 7,155 | $104.82 | $749,987.10 |
DisclosureSEC source: 0001127602-16-048888 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,572 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:32 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Tax withholdingCommon Stock | 6,924 | $104.82 | $725,773.68 |
DisclosureSEC source: 0001127602-16-048888 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,118.059 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:39 UTC |
GOLD STEPHEN JEVP & CIO
|
GrantStock Option · Derivative | 48,395 | $104.82 Strike: $104.82 | $5,072,763.90 |
DisclosureSEC source: 0001127602-16-048894 · form4.xml · derivative · entry 8 GOLD STEPHEN J · CIK 0001252005 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,395 Underlying: Common Stock · 48,395 shares Expires 2023-04-01 F5 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:39 UTC |
GOLD STEPHEN JEVP & CIO
|
Exercise / conversionStock Option · Derivative | 21,922 | $0.00 Strike: $47.29 | $0.00 |
DisclosureSEC source: 0001127602-16-048894 · form4.xml · derivative · entry 7 GOLD STEPHEN J · CIK 0001252005 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,238 Underlying: Common Stock · 21,922 shares Expires 2022-07-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 07/09/2015. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:39 UTC |
GOLD STEPHEN JEVP & CIO
|
GrantCommon Stock (restricted) | 6,439 | $104.82 | $674,935.98 |
DisclosureSEC source: 0001127602-16-048894 · form4.xml · nonDerivative · entry 4 GOLD STEPHEN J · CIK 0001252005 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,862 F3 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:39 UTC |
GOLD STEPHEN JEVP & CIO
|
Tax withholdingCommon Stock | 1,546 | $104.82 | $162,051.72 |
DisclosureSEC source: 0001127602-16-048894 · form4.xml · nonDerivative · entry 3 GOLD STEPHEN J · CIK 0001252005 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,560.3558 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:39 UTC |
GOLD STEPHEN JEVP & CIO
|
SaleCommon Stock | 21,922 | $105.00 | $2,301,810.00 |
DisclosureSEC source: 0001127602-16-048894 · form4.xml · nonDerivative · entry 2 GOLD STEPHEN J · CIK 0001252005 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,126.3558 F1 · kind: Sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:39 UTC |
GOLD STEPHEN JEVP & CIO
|
Exercise / conversionCommon Stock | 21,922 | $47.29 | $1,036,691.38 |
DisclosureSEC source: 0001127602-16-048894 · form4.xml · nonDerivative · entry 1 GOLD STEPHEN J · CIK 0001252005 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,048.3558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:57 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
GrantStock Option · Derivative | 21,509 | $104.82 Strike: $104.82 | $2,254,573.38 |
DisclosureSEC source: 0001127602-16-048897 · form4.xml · derivative · entry 3 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,509 Underlying: Common Stock · 21,509 shares Expires 2023-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 22:57 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
GrantCommon Stock (restricted) | 2,862 | $104.82 | $299,994.84 |
DisclosureSEC source: 0001127602-16-048897 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,515 F1 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:05 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
GrantStock Option · Derivative | 25,093 | $104.82 Strike: $104.82 | $2,630,248.26 |
DisclosureSEC source: 0001127602-16-048898 · form4.xml · derivative · entry 3 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,093 Underlying: Common Stock · 25,093 shares Expires 2023-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:05 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
GrantCommon Stock (restricted) | 3,339 | $104.82 | $349,993.98 |
DisclosureSEC source: 0001127602-16-048898 · form4.xml · nonDerivative · entry 2 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,988 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:05 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
Tax withholdingCommon Stock | 1,155 | $104.82 | $121,067.10 |
DisclosureSEC source: 0001127602-16-048898 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,353 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:15 UTC |
Bisaccia LisaEVP and Chief HR Officer
|
GrantStock Option · Derivative | 39,433 | $104.82 Strike: $104.82 | $4,133,367.06 |
DisclosureSEC source: 0001127602-16-048901 · form4.xml · derivative · entry 5 Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,433 Underlying: Common Stock · 39,433 shares Expires 2023-04-01 F3 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:15 UTC |
Bisaccia LisaEVP and Chief HR Officer
|
GrantCommon Stock (restricted) | 5,247 | $104.82 | $549,990.54 |
DisclosureSEC source: 0001127602-16-048901 · form4.xml · nonDerivative · entry 2 Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,613.0004 F2 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:15 UTC |
Bisaccia LisaEVP and Chief HR Officer
|
Tax withholdingCommon Stock | 4,625 | $104.82 | $484,792.50 |
DisclosureSEC source: 0001127602-16-048901 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,955 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:21 UTC |
Sussman AndrewEVP & Pres, CVS MinuteClinic
|
GrantStock Option · Derivative | 23,301 | $104.82 Strike: $104.82 | $2,442,410.82 |
DisclosureSEC source: 0001127602-16-048902 · form4.xml · derivative · entry 5 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,301 Underlying: Common Stock · 23,301 shares Expires 2023-04-01 F4 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:21 UTC |
Sussman AndrewEVP & Pres, CVS MinuteClinic
|
GrantCommon Stock (restricted) | 3,100 | $104.82 | $324,942.00 |
DisclosureSEC source: 0001127602-16-048902 · form4.xml · nonDerivative · entry 3 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,313 F3 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:21 UTC |
Sussman AndrewEVP & Pres, CVS MinuteClinic
|
Tax withholdingCommon Stock | 1,319 | $104.82 | $138,257.58 |
DisclosureSEC source: 0001127602-16-048902 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,473 F2 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:21 UTC |
Sussman AndrewEVP & Pres, CVS MinuteClinic
|
SaleCommon Stock | 2,844 | $105.00 | $298,620.00 |
DisclosureSEC source: 0001127602-16-048902 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS MinuteClinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,041 F1 · kind: Sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| April 01, 2016 Filed Apr 5, 2016 23:28 UTC |
Kraft Robert O.EVP and President - Omnicare
|
GrantStock Option · Derivative | 23,301 | $104.82 Strike: $104.82 | $2,442,410.82 |
DisclosureSEC source: 0001127602-16-048903 · form4.xml · derivative · entry 4 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,301 Underlying: Common Stock · 23,301 shares Expires 2023-04-01 F2 · derivative.exercise_date: Option becomes exercisable in four equal annual installments, commencing 4/1/2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.